Search Results - Kirsha S. Gordon

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Polypharmacy and medical intensive care unit (MICU) admission and 10-year all-cause mortality risk among hospitalized patients with and without HIV.

    Polypharmacy and medical intensive care unit (MICU) admission and 10-year all-cause mortality risk among hospitalized patients with and without HIV. by Kirsha S Gordon, Kristina Crothers, Adeel A Butt, E Jennifer Edelman, Cynthia Gibert, Margaret M Pisani, Maria Rodriguez-Barradas, Christina Wyatt, Amy C Justice, Kathleen M Akgün

    Published 2022-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Strategy for addressing research-site overlap in pragmatic clinical trials: lessons learned from the NIH-DOD-VA Pain Management Collaboratory (PMC)

    Strategy for addressing research-site overlap in pragmatic clinical trials: lessons learned from the NIH-DOD-VA Pain Management Collaboratory (PMC) by Mary Geda, Steven Z. George, Diana J. Burgess, Dylan V. Scarton, William T. Roddy, Kirsha S. Gordon, Paul F. Pasquina, Cynthia A. Brandt, Robert D. Kerns, Peter Peduzzi, on behalf of the NIH-DoD-VA Pain Management Collaboratory

    Published 2020-12-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Differences in COVID-19 testing and adverse outcomes by race, ethnicity, sex, and health system setting in a large diverse US cohort

    Differences in COVID-19 testing and adverse outcomes by race, ethnicity, sex, and health system setting in a large diverse US cohort by Celeena Jefferson, Eric Watson, Julia M. Certa, Kirsha S. Gordon, Lesley S. Park, Gypsyamber D’Souza, Lorie Benning, Alison G. Abraham, Deana Agil, Sonia Napravnik, Michael J. Silverberg, Wendy A. Leyden, Jacek Skarbinski, Carolyn Williams, Keri N. Althoff, Michael A. Horberg

    Published 2022-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Differences in COVID-19 testing and adverse outcomes by race, ethnicity, sex, and health system setting in a large diverse US cohort.

    Differences in COVID-19 testing and adverse outcomes by race, ethnicity, sex, and health system setting in a large diverse US cohort. by Celeena Jefferson, Eric Watson, Julia M Certa, Kirsha S Gordon, Lesley S Park, Gypsyamber D'Souza, Lorie Benning, Alison G Abraham, Deana Agil, Sonia Napravnik, Michael J Silverberg, Wendy A Leyden, Jacek Skarbinski, Carolyn Williams, Keri N Althoff, Michael A Horberg, NA-ACCORD Corona-Infectious-Virus Epidemiology Team (CIVET)

    Published 2022-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Polypharmacy-associated risk of hospitalisation among people ageing with and without HIV: an observational study

    Polypharmacy-associated risk of hospitalisation among people ageing with and without HIV: an observational study by Amy C Justice, ProfMD, Kirsha S Gordon, PhD, Jonathon Romero, BSc, E Jennifer Edelman, MD, Benjamin J Garcia, PhD, Piet Jones, MSc, Saye Khoo, ProfMD, Vincent Lo Re, III, MD, Christopher T Rentsch, PhD, Janet P Tate, ScD, Alice Tseng, PharmD, Julie Womack, PhD, Daniel Jacobson, PhD

    Published 2021-10-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    What internal medicine attendings talk about at morning report: a multicenter study

    What internal medicine attendings talk about at morning report: a multicenter study by Jeffrey W. Redinger, Daniel B. Heppe, Tyler J. Albert, Paul B. Cornia, Kirsha S. Gordon, Cherinne Arundel, Joel M. Bradley, Laura M. Caputo, Jonathan W. Chun, Jessica E. Cyr, Erik T. Ehlers, Michelle M. Guidry, Anand D. Jagannath, Brian K. Kwan, James D. Laudate, Christine A. Mitchell, Andrea C. Smeraglio, Joseph R. Sweigart, Matthew G. Tuck, Craig G. Gunderson

    Published 2023-02-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: